FEBS Letters · 1996 · 64 citations · 18 references
Life SciencesBiochemistryMolecular BiologyCellular BiochemistryEnzymologyProtein BiochemistryAmyloid FormationDiabetes MellitusPancreatic EndocrinologyPancreatic HormonesProteolytic EnzymesProteolytic ProcessingAmyloid Beta PeptidesAmyloidogenic PeptidesEndocrine Cell Secretory GranulesPancreatic Islet CellsProteolytic Degradation Of PeptidesProteolytic Enzyme ActivityProteolytic Processing AnalysisType 2 Diabetes Biochemistry
Islet amyloid polypeptide (IAPP), 'amylin', is the component peptide of islet amyloid formed in Type 2 diabetes. IAPP is expressed in islet beta-cells and is derived from a larger precursor, proIAPP, by proteolysis. An in vitro translation/translocation system was used to separately examine processing of human proIAPP by the beta-cell endopeptidases PC2, PC3 or furin. ProIAPP was converted to mature IAPP by PC2 but there was little conversion by furin or PC3. These data are consistent with processing of proIAPP in beta-cell secretory granules. Abnormal cellular proteolysis associated with type 2 diabetes could contribute to IAPP amyloidosis.
18
AlanRobert Gurd, R. I. Wilson · The Lancet · 1972 · 526 citations
Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells
Steven E. Kahn, David A. D’Alessio, Michael W. Schwartz et al. · Diabetes · 1990 · 451 citations · Full text
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
Anne Clark, Claire E. Lewis, A.C. Willis et al. · The Lancet · 1987 · 357 citations
Medicine, Endocrinology, Pathology +10